Immunotherapy and Bladder Cancer
1 Tampilan
• 06/16/23
0
0
Menanamkan
administrator
Pelanggan
Researchers at Dana-Farber Cancer Institute are looking to expand treatment options for bladder cancer patients beyond surgery and chemotherapy. In what’s known as the BLASST trial, they’re adding in immunotherapy before any surgery takes place in muscle-invasive bladder cancer.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru